GENOWAY SA (ALGEN.PA) Stock Overview
Europe - EPA:ALGEN - FR0004053510 - Common Stock
ALGEN.PA Key Statistics, Chart & Performance
The current stock price of ALGEN.PA is 2.88 EUR. In the past month the price increased by 5.49%. In the past year, price decreased by -23.61%.
ALGEN.PA Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| 4AB.DE | ABBVIE INC | 21.71 | 346.25B | ||
| 1AMGN.MI | AMGEN INC | 13.65 | 136.64B | ||
| AMG.DE | AMGEN INC | 13.64 | 136.47B | ||
| GIS.DE | GILEAD SCIENCES INC | 14.7 | 120.41B | ||
| VX1.DE | VERTEX PHARMACEUTICALS INC | 24.18 | 89.54B | ||
| ARGX.BR | ARGENX SE | 92.74 | 41.78B | ||
| 22UA.DE | BIONTECH SE-ADR | N/A | 21.68B | ||
| IDP.DE | BIOGEN INC | 9.92 | 19.84B | ||
| 0QF.DE | MODERNA INC | N/A | 9.31B | ||
| 1MRNA.MI | MODERNA INC | N/A | 9.08B | ||
| ABVX.PA | ABIVAX SA | N/A | 5.89B | ||
| 2X1.DE | ABIVAX SA | N/A | 5.57B |
Related stock screener links
About ALGEN.PA
Company Profile
genOway SA engages in the development of genetically modified mouse, rat, and cellular models for biopharmaceutical and research companies. The company is headquartered in Lyon, Auvergne-Rhone-Alpes and currently employs 143 full-time employees. The company went IPO on 2007-05-04. The firm offers an array of services which include site specific transgenesis, random insertion based transgenic models, gene overexpression, humanization, gene deletion and gene knock-down (RNA interference). The Company’s clients include multinational biopharmaceutical companies, such as Roche, Novartis and Servier, as well as universities and research institutes, notably Boston University, University of Tokyo, Johann Wolfgang Goethe University Hospital Frankfurt and Centre National de Genotypage.
Company Info
GENOWAY SA
Technopark 2, 31 Rue Saint Jean-de-Dieu
Lyon AUVERGNE-RHONE-ALPES FR
Employees: 128
Phone: 33437654100
GENOWAY SA / ALGEN.PA FAQ
What is the stock price of GENOWAY SA today?
The current stock price of ALGEN.PA is 2.88 EUR. The price decreased by -0.69% in the last trading session.
What is the ticker symbol for GENOWAY SA stock?
The exchange symbol of GENOWAY SA is ALGEN and it is listed on the Euronext Paris - Matif exchange.
On which exchange is ALGEN.PA stock listed?
ALGEN.PA stock is listed on the Euronext Paris - Matif exchange.
What is the price forecast or stock price prediction for GENOWAY SA stock?
9 analysts have analysed ALGEN.PA and the average price target is 6.02 EUR. This implies a price increase of 108.96% is expected in the next year compared to the current price of 2.88. Check the GENOWAY SA stock analysts ratings, price target forecast and up-and down grades for more detailed information.
What is GENOWAY SA worth?
GENOWAY SA (ALGEN.PA) has a market capitalization of 27.30M EUR. This makes ALGEN.PA a Nano Cap stock.
How many employees does GENOWAY SA have?
GENOWAY SA (ALGEN.PA) currently has 128 employees.
What are the support and resistance levels for GENOWAY SA (ALGEN.PA) stock?
GENOWAY SA (ALGEN.PA) has a support level at 2.78 and a resistance level at 2.97. Check the full technical report for a detailed analysis of ALGEN.PA support and resistance levels.
Is GENOWAY SA (ALGEN.PA) expected to grow?
The Revenue of GENOWAY SA (ALGEN.PA) is expected to decline by -7.14% in the next year. Check the estimates tab for more information on the ALGEN.PA EPS, Sales, EBIT and EBITDA future analyst estimates.
Should I buy GENOWAY SA (ALGEN.PA) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of ALGEN.PA, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of ALGEN.PA, evaluating the profitability, health, valuation and growth aspects
- GENOWAY SA (ALGEN.PA) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- GENOWAY SA (ALGEN.PA) Sales and EPS estimates to see what analysts future expectations are.
- GENOWAY SA (ALGEN.PA) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- GENOWAY SA (ALGEN.PA) Insider and Institutional Ownership to learn about the owners and their transactions.
- GENOWAY SA (ALGEN.PA) Stock Chart to make your own analysis
- GENOWAY SA (ALGEN.PA) Latest news and press-releases to stay up to date.
Does GENOWAY SA (ALGEN.PA) stock pay dividends?
ALGEN.PA does not pay a dividend.
What is the Price/Earnings (PE) ratio of GENOWAY SA (ALGEN.PA)?
The PE ratio for GENOWAY SA (ALGEN.PA) is 13.71. This is based on the reported non-GAAP earnings per share of 0.21 and the current share price of 2.88 EUR. Check the full fundamental report for a full analysis of the valuation metrics for ALGEN.PA.
ALGEN.PA Technical Analysis
ChartMill assigns a technical rating of 1 / 10 to ALGEN.PA. When comparing the yearly performance of all stocks, ALGEN.PA is a bad performer in the overall market: 92.56% of all stocks are doing better.
ALGEN.PA Fundamental Analysis
ChartMill assigns a fundamental rating of 6 / 10 to ALGEN.PA. While ALGEN.PA has a great profitability rating, there are some minor concerns on its financial health.
ALGEN.PA Financial Highlights
Over the last trailing twelve months ALGEN.PA reported a non-GAAP Earnings per Share(EPS) of 0.21. The EPS increased by 18.41% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 5.86% | ||
| ROA | 3.96% | ||
| ROE | 7.06% | ||
| Debt/Equity | 0.26 |
ALGEN.PA Forecast & Estimates
9 analysts have analysed ALGEN.PA and the average price target is 6.02 EUR. This implies a price increase of 108.96% is expected in the next year compared to the current price of 2.88.
For the next year, analysts expect an EPS growth of -100% and a revenue growth -7.14% for ALGEN.PA